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Background: A century of research has established that cancers arise from tissues exposed to carcinogens only after
long latencies of years to decades and have individual clonal karyotypes. Since speciation from known precursors also
depends on long latencies and new species also have individual karyotypes, we and others have recently proposed
that carcinogenesis is a form of speciation. According to this theory karyotypic evolutions generate new cancer species
from normal cells as follows: Carcinogens induce aneuploidy (Figure 1). By unbalancing thousands of genes aneuploidy
automatically destabilizes the karyotype and thus catalyzes random karyotypic variations. Selections of variants with
proliferative phenotypes form non-clonal hyperplasias with persistently varying karyotypes. Very rare karyotypic
variations form new cancer species with individual clonal karyotypes. Despite destabilization by the resulting congenital
aneuploidies, cancer karyotypes are stabilized within narrow margins of variation by clonal selections for cancer-specific
autonomy. Because all non-cancerous aneuploidies are unstable, all aneusomies of prospective cancers are joined in
single-steps, rather than gradually. Since this mechanism is very inefficient, it predicts long latent periods from
carcinogens to cancers and individual clonal cancer karyotypes.
Results: Here we have tested the predicted roles of karyotypic evolutions during the time course of carcinogenesis in an
established experimental system. In this system injection of nitrosourea induces in female rats non-invasive mammary
hyperplasias (“tumors”) after two or more months, and invasive carcinomas after six or more months. Accordingly four
specific predictions were tested: (1) Invasive cancers are late and carry individual clonal karyotypes and phenotypes, (2)
Persistent hyperplasias carry non-clonal karyotypes, (3) Non-clonal hyperplasias generate clonal cancers spontaneously but
rarely, (4) Cancer-karyotypes arise with all individual clonal aneusomies in single-steps. All four predictions were
experimentally confirmed.
Conclusions: Our results along with the literature reveal a coherent karyotypic mechanism of carcinogenesis:
Carcinogens induce aneuploidy. The inherent instability of aneuploidy automatically catalyzes new karyotypic variations.
Aneuploid karyotypes with proliferative phenotypes form varying non-clonal hyperplasias. Rare variations form cancer
species with individual clonal karyotypes, which are stabilized by clonal selection for autonomy. The low odds of this
mechanism explain the long latencies of carcinogenesis, the individuality and karyotypic clonality of cancers.
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A century of cancer research has established that can-
cers arise from tissues exposed to carcinogens only after
long latencies of years to decades [1-9] and have individ-
ual clonal karyotypes [2,10-20].
Several attempts to explain these characteristics of car-
cinogenesis with the currently prevailing mutation the-
ory of cancer have been unsuccessful. For example, the
mutation theory explains the long latencies of years to
decades from atomic bomb explosions in 1945 [5,9] or
from X-ray therapies of tuberculosis [6] to subsequent
cancers by requirements of subsequent mutations. This
seems odd, however, in view of the huge loads of muta-
genic radiations long before carcinogenesis. Further, a
requirement of subsequent mutations does not explain,
why even the steady fraction of any population, which
has already accumulated or inherited all but one of the
hypothetically required mutations, would not have de-
veloped cancers without delay. Moreover, the multi-
mutation theory of the long latencies of carcinogenesis
does not explain the persistent, non-clonal preneoplastic
aneuploidies in carcinogen-exposed animals and cancer-
free people [10,21-24], specifically in the well-studied
survivors of atom bombs [25-27]. (See more examples
in, ‘Test-2: do persistent hyperplasias carry varying aneu-
ploidies?’). The mutation theory also does not explain,Figure 1 The speciation theory of cancer. This theory postulates that ca
or gains of entire chromosomes or parts of chromosomes at rates, termed
destabilizes the karyotype, and thus catalyzes random karyotypic variations
proliferative phenotypes form non-clonal hyperplasias* with persistently va
rare karyotypic variations form new cancer species with individual clonal ka
congenital aneuploidies, cancer karyotypes are stabilized within narrow ma
of growth. Within these margins cancer karyotypes are clonally flexible at a
all clonal aneusomies of cancers must be joined in single-steps, rather than
pre-cancerous aneuploidy. Since this mechanism is very inefficient, it predic
clonal cancer karyotypes. *Hyperplasias are defined here according to the O
caused by an increase in the reproductive rate of its cells, often as an initiawhy all cancers have individual clonal karyotypes and
phenotypes, instead of diploid karyotypes with specific
sets of mutations [15,20,28]. Since the currently prevail-
ing mutation theory does not answer these questions,
the mechanism of carcinogenesis is still a matter of de-
bate [5,29-31]. Accordingly, Brash and Cairns stated in
2009, “mutagenic carcinogens cause just one or two
events and that these are then followed by steps that ac-
cumulate solely with the passage of time” [32].
Since speciation depends on “the passage of time” and
on the generation of new individual karyotypes, several
researchers, including us, have recently proposed that
carcinogenesis is a form of speciation [16,19,33-37].
According to this theory karyotypic evolutions gener-
ate new autonomous cancer species from normal cells
as follows: Carcinogens induce random aneuploidy
(Figure 1). By unbalancing thousands of genes aneu-
ploidy automatically destabilizes the karyotype, and thus
catalyzes random karyotypic variations [38-40]. Selec-
tions of variants with proliferative phenotypes form
non-clonal hyperplasias with persistently varying karyo-
types. (Hyperplasias are defined according to the Oxford
American Dictionary as “The enlargement of an organ
or tissue caused by an increase in the reproductive rate
of its cells, often as an initial stage in the development
of cancer.”) Very rare karyotypic variations form newrcinogens or spontaneous events induce aneuploidy, namely losses
m1. By unbalancing thousands of genes aneuploidy automatically
at aneuploidy-dependent rates, termed m2. Selections of variants with
rying karyotypes. Variants without proliferative phenotypes perish. Very
ryotypes at very low rates, termed m3. Despite destabilization by their
rgins of variation by clonal selections for cancer-specific autonomy
neuploidy-dependent rates, termed [m2]. To generate new cancers
gradually, because of the inherent instability of non-cancerous or
ts long latent periods from carcinogens to cancers and individual
xford American Dictionary as “The enlargement of an organ or tissue
l stage in the development of cancer.”








*Isolated one year after injection of Nitrosourea. See reference [44] and
Results, Test-1: are carcinomas late and carry individual clonal karyotypes and
phenotypes? and Test-2: do persistent hyperplasias carry non-clonal
aneuploidies? below.
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pite destabilization by the resulting congenital aneu-
ploidies, cancer karyotypes are stabilized within narrow
margins of variation by clonal selections for cancer-
specific autonomy [19] (Figure 1). Cancer-specific
karyotypic flexibility is thus a dynamic equilibrium
between destabilization by native aneuploidy and
stabilization by selection for cancer-specific autonomy
[17,19]. Owing to this inherent flexibility the karyotypes
of cancer cells can also revert to a non-cancerous aneu-
ploidy. Because all non-cancerous aneuploidies are un-
stable, all aneusomies of prospective cancer cells are
joined in single-steps, rather than gradually. Since this
mechanism is very inefficient, it predicts long latent pe-
riods from carcinogens to cancers and individual clonal
cancer karyotypes.
This theory does not apply to clonal hyperplasias with
chromosomally rearranged but balanced karyotypes, as
for example the chronic myelogenous leukemia, which
is a hyperplasia of terminally differentiating myeloblasts
[41,42]. Such clonal hyperplasias might be caused by
chromosome rearrangements or by gene mutations.
Our theory would, however, apply to the late ‘blast
crises’ of myelogenous leukemias, in which the
genomically balanced karyotype is displaced by new an-
euploid karyotypes forming neoplastic clones of non-
differentiating cells [28,41-43].
In the following we test four specific predictions of the
speciation theory of cancer according to which rare selec-
tions from random karyotypic evolutions determine the time
course of carcinogenesis and the individuality of cancers: (1)
Invasive cancers are late and carry individual clonal karyo-
types and phenotypes, (2) Persistent hyperplasias carry non-
clonal aneuploidies, (3) Non-clonal hyperplasias generate
clonal cancers spontaneously but rarely, (4) Cancer-
karyotypes arise with all clonal aneusomies in single-steps,
rather than gradually.
To test these predictions we have analyzed here the
karyotypes and phenotypes of six “primary mammary
tumors”, which Aldaz et al. isolated from rats about one
year (9 to 12 months) after injection of nitrosourea [44].
The six tumors were labeled “RMT” (rat mammary
tumor) 47–3, 37–2, 65, 58, 54, 61. Table 1 provides a
brief description of cancer-relevant characteristics of
these six tumors. In this long-established experimental
system a single injection of nitrosourea induces in fe-
male rats non-invasive “mammary tumors” or hyperpla-
sias after two or more months, and invasive “tumors” or
carcinomas with “abnormal” karyotypes after six or
more months [44-48]. Thus, based on the time from the
initiating nitrosourea-treatment, the six tumors we
studied here could be either preneoplastic non-clonal
hyperplasias or cancers with individual clonal karyo-
types and phenotypes.Results
In the following we describe the four tests of the roles of
karyotypic evolutions in carcinogenesis outlined above,
based on karyotypic analyses of the six “mammary tu-
mors” isolated by Aldaz et al. from rats about one year
after injection of nitrosourea [44], as described in Table 1
and below. In addition we adduce evidence that cancer
karyotypes arise with all prospective clonal cancer-specific
aneusomies in single-steps, rather than gradually, because
non-cancerous aneuploid intermediates are too unstable
to support gradual accumulations.
Test-1: are carcinomas late and carry individual clonal
karyotypes and phenotypes?
The speciation theory attributes the long latencies from
carcinogen to carcinogenesis and the clonal individuality of
cancers to very rare, and thus typically late karyotypic varia-
tions, which generate new autonomous cancer-species with
individual clonal karyotypes. To test these predictions of
the speciation theory, we first analyzed those two of the six
RMT “tumors” from Aldaz et al., which were invasive and
“metastatic” at the time of isolation a year after nitrosourea,
namely RMT 47–3 and 37–2 [44] (Table 1). Since these
two “tumors” were metastatic and had been transplanted to
isogenic rats several times prior to isolation, they were
probably carcinomas [44,48]. The hyphenated numbers in-
dicate transplantations of primary tumors.
Representative karyotypes of RMT 47–3 and 37–2,
shown in Figure 2A and B, indicate that the two carcin-
omas have individual karyotypes.
To determine whether these karyotypes are clonal, as
predicted by the speciation theory (Figure 1), multiple
karyotypes of the same cancer must be compared. For
this purpose we have used 3-dimensional arrays of 20
karyotypes, which list chromosome numbers on the x-
axis, chromosome copy numbers on the y-axis and the
numbers of karyotypes arrayed on the z-axis. This
method and the preparation of 20 individual karyotypes
of the invasive “tumors” RMT 47–3 and 37–2 from
color-coded metaphase chromosomes followed pub-
lished procedures [17,24,49].
Carcinoma RMT 47-3 Carcinoma RMT 37-2, Clone-1 Neoplastic Clone RMT-CN 65 
Neoplastic Clone RMT-CN 58 Neoplastic Clone RMT-CN 54 Neoplastic Clone RMT-CN 61 
CBA
FED
Figure 2 Karyotypes of two invasive rat mammary carcinomas and of four neoplastic clones evolved from non-clonal hyperplasias in vitro.
The karyotypes of the two rat mammary carcinomas RMT 47–3 (A) and 37–2 (B) were prepared from short-term cultures of the two carcinomas
treated with colcemid for several hours following published procedures [17,49]. Prior to karyotyping the metaphase chromosomes were hybridized
with DNA probes carrying chromosome-specific fluorescent colors (Methods). The chromosomes were then arranged into conventional karyotypes
with a computer-assisted Zeiss microscope [17,49]. The karyotypes of the four clonal neoplasias RMT-CN 65 (C), RMT-CN 58 (D), RMT-CN 54 (E) and
RMT-CN 61 (F), which had evolved spontaneously from cultures of preneoplastic hyperplasias propagated in vitro, were prepared as described for the
two carcinomas.
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chromosome copy numbers form parallel lines in karyo-
type arrays, clonality and individuality can be recognized
at a glance - much like individual signatures. As an ex-
ample we show in Figure 3A the 100%-clonal karyotype
array of a normal female rat.
The karyotype array of the invasive tumor RMT 47–3
and the underlying quasi-clonal chromosome copy num-
bers of the 20 RMT 47–3 karyotypes are shown in
Figure 3B and in the corresponding table. The table indi-
cates the average chromosome number per RMT 47–3
cell was 43 ± 2. By contrast, the normal chromosome
number of rats is 42. The array shows at a glance that
the chromosome copy numbers of the invasive RMT
47–3 tumor are highly, 70-100% clonal. The minority of
0-30% of non-clonal chromosome copy numbers oscil-
lated ±1 around clonal averages. The resulting clonal
heterogeneity is consistent with the dynamic equilibrium
between the inherent instability of the congenital aneu-
ploidy of cancers and the clonal selection for cancer-specific autonomy that stabilizes the karyotypes of cancers
within narrow margins (see above, Figure 1, Background
and references [17,19]). The invasive tumor RMT 47–3
thus has a near-clonal karyotype, as predicted for invasive
cancers by the speciation theory.
With regard to its individuality the karyotype-array of
RMT 47–3 was first compared to that of the normal rat
and then to further rat cancers (below). As can be seen
in Figure 3A and B, the karyotype of RMT 47–3 differs
from that of the normal female rat in three clonal, nu-
merical chromosome alterations also termed aneuso-
mies, namely trisomies 1, 4 and 12 (see also Figure 2A),
and in a low clonal percentage of heterogeneity. This re-
sult extends and confirms a previous karyotypic analysis
of RMT 47–3 by Aldaz et al. from 1992 [44] and thus
also confirms the predicted clonal stability of this carcin-
oma from the time of its isolation to the present re-
analysis. It is shown below that the RMT 47–3 karyotype
also differs from those of the five other neoplastic RMT
clones described below.
Figure 3 Karyotype arrays of a normal female rat and of the rat mammary carcinoma RMT 47–3. Karyotype arrays are three-dimensional
tables, which list the chromosome numbers of individual karyotypes on the x-axis, the copy numbers of each chromosome on the y-axis, and the
number of karyotypes arrayed on the z-axis. In such arrays the karyotypes with identical, clonal chromosome copy numbers form parallel lines
(see text). (A) An array of 20 karyotypes of a normal, diploid female rat. (B) An array of 20 karyotypes of the rat mammary carcinoma RMT 47–3.
The karyotype array and the attached table show that the numbers of RMT 47–3 chromosomes per cell are quasi-clonal, averaging 43 ± 2. The
data also show that the copy numbers of RMT 47–3 chromosomes are 70-100% clonal. The minority of non-clonal chromosomes oscillated within
narrow margins of ±1 of clonal values, as predicted by the speciation theory (Background and Figure 1).
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karyotype of RMT 47–3 encodes a clonal and thus a
uniform cellular phenotype. As shown in Figure 4A, the
morphological uniformity of a population of RMT 47–3cells confirms this prediction. The cellular morphology
of RMT 47–3 was also individual based on comparisons
with those of the five other clonal rat mammary carcin-
omas and neoplastic clones described below. (No
Figure 4 Cellular morphologies of two rat mammary carcinomas and of four neoplastic clones evolved from rat hyperplasias in vitro.
Cells of the rat mammary carcinomas RMT 47–3 and 37–2 and of four clonal neoplasias derived from mammary hyperlasias termed RMT-CN 65,
RMT-CN 58, RMT-CN 54 and RMT-CN 61 were photographed in cell culture dishes at a magnification of 100x with a phase-contrast microscope.
The following individualities were observed: (A) A dense monolayer of polygonal cells of the RMT 47–3 carcinoma, (B) Three-dimensional colonies
of round and refractile cells of the carcinoma RMT 37–2 clone 1, (C) A dense monolayer of fusiform cells of the clonal neoplasia RMT-CN 65, (D)
A three-dimensional multilayer of pleomorphic-round cells of the clonal neoplasia RMT-CN 58, (E) A relatively flat monolayer of fusiform, triangular
cells of the clonal neoplasia RMT-CN 54, (F) A three-dimensional cell layer of elongated refractile cells of the clonal neoplasia RMT-CN 61.
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origin is not known.) Thus RMT 47–3 has an individual
clonal karyotype and phenotype.
Next, we analyzed the second invasive and metastatic
rat mammary tumor, and thus probable carcinoma RMT
37–2 for karyotypic clonality and individuality. As shown
by the two karyotype-arrays in Figure 5A and B and the
corresponding tables, RMT 37–2 consisted of two related
but distinct clones. Both clone-1 and −2 were near diploid,
containing clonal averages of 43 and 42 chromosomes per
cell respectively. The copy numbers of these chromo-
somes were between 87 and 100% clonal. Both RMT 37–2
clones shared a monosomy of the normal chromosome 1
and one clonal, oversized chromosome 1-derived marker
chromosome, in which about half of the normal chromo-
some 1 was duplicated (See Figure 2B). On the other
hand, clone-1 differed from clone-2 in a clone-1-specific
monosomy 7, a trisomy 12 and a clone-1-specific marker
chromosome. Clone 2 also contained a clone-2-specific
marker chromosome. It follows that the two clones either
derived from a common ancestor or from each other.
The finding of a distinctive chromosome 1-derived
marker chromosome in RMT 37–2 again confirmed and
extended a prior observation of this marker by Aldaz et al.
[44]. Taken together the two carcinomas confirm the ideathat, despite inherent flexibility, the karyotypes of cancers
are stable, but flexible clones (Figure 1).
The clonality of the two related RMT 37–2 clones pre-
dicted again that they should encode uniform cellular phe-
notypes. It is shown in Figure 4B that the uniform
morphology of the cells of RMT 37–2 clone-1 confirmed
this prediction.
Although the exact times of the origins of the two car-
cinomas after the initiating nitrosourea injection cannot
be determined based on the available data, we can esti-
mate that the latent periods from nitrosourea to the ori-
gins of the two clonal carcinomas were between 6 and
12 months. This follows, because (a) the two carcinomas
were isolated about one year after nitrosourea, and (b) no
invasive cancers have been observed in this system prior
to six months after nitrosourea by others, and us [44,47].
Test-1-specific conclusions
1. The karyotypic and phenotypic individualities and
clonalities of the invasive tumors or carcinomas
confirm the prediction of the speciation theory that
the cancers RMT 47–3 and RMT 37–2 originated
from individual clonogenic karyotypes, rather than
from common mutations, as for example from a
Figure 5 (See legend on next page.)
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Figure 5 Karyotype arrays of the rat mammary carcinoma RMT 37–2. The mammary carcinoma RMT 37–2 consisted of two clones with distinct but
related karyotype arrays, clones 1 (A) and 2 (B). As shown in the attached table the numbers of chromosomes per RMT 37–2 cell are quasi-clonal, averaging
of 43 ± 1 and 42 ± 1 respectively. The copy numbers of the normal and marker chromosomes of the two clones are between 80 and 100% clonal. Both RMT
37–2 clones shared a monosomy of the normal chromosome 1 and one clonal, oversized chromosome 1-derived marker chromosome, in which about half
of the normal chromosome 1 was duplicated (See Figure 2B). On the other hand, clone-1 differed from clone-2 in a clone-1-specific monosomy 7, a trisomy
12 and a marker chromosome der(7). And clone 2 differed from clone 1 in a marker chromosome of its own. It follows that the two clones either derived
from a common ancestor or from each other. The individuality of the two RMT 37–2 karyotypes is evident from comparisons with the karyotype arrays of
RMT 47–3 and the normal rat shown in Figure 3.
Table 2 Non-clonal hyperplasia RMT 65: 10 aneuploid
cells in a sample of 20
Karyotypes 1 2 3 4 5 6 7 8 9 10
Total no. of chromosomes 85 79 84 81 76 70 83 86 84 84
Chromosomes
1 3 3 4 4 4 4 4 4 4 4
2 3 3 3 3 5 4 4 4 4 4
3 4 4 4 3 4 3 3 4 4 4
4 4 3 5 4 4 3 4 6 4 4
5 4 4 3 3 4 3 4 4 4 4
6 4 4 4 4 4 3 4 4 4 4
7 4 4 4 4 4 3 4 3 4 4
8 4 4 4 4 3 3 4 4 4 4
9 4 4 5 4 2 3 4 5 4 4
10 4 4 4 4 4 4 4 4 4 4
11 4 4 4 4 3 3 3 4 4 4
12 4 3 5 4 4 2 4 5 4 4
13 4 3 4 4 4 3 4 4 4 4
14 4 3 3 4 4 3 4 4 4 4
15 4 4 4 4 4 3 4 3 4 4
16 4 4 4 4 3 4 4 4 3 4
17 4 4 4 4 4 4 4 4 4 4
18 4 4 4 4 4 3 4 4 4 4
19 4 4 4 4 3 4 4 4 4 3
20 4 3 4 4 3 4 4 4 4 4
X 4 4 4 4 2 4 4 4 4 4
Y 0 0 0 0 0 0 0 0 0 0
der(19;8) 0 0 0 0 0 0 0 0 0 1
der (1;2) 1 1 0 0 0 0 0 0 0 0
der (1) 2 0 0 0 0 0 0 0 0 0
der (16;11) 0 0 0 0 0 0 0 0 1 0
der (3;11) 0 0 0 0 0 0 1 0 0 0
der (1;13) 0 1 0 0 0 0 0 0 0 0
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Discussion).
2. The long, although not accurate latent periods of 6
to 12 months from nitrosourea to the two
carcinomas confirm the inevitably inefficient and
thus slow chromosomal mechanism of
carcinogenesis via random karyotypic variations
predicted by the speciation theory.
Test-2: do persistent hyperplasias carry non-clonal
aneuploidies?
Next, we tested the prediction of the speciation theory
that persistent hyperplasias (defined in Background and
Figure 1) carry varying non-clonal aneuploidies with
proliferative phenotypes. For this purpose we have kar-
yotyped the four “tumors” isolated by Aldaz et al.
namely RMT 65, 58, 54 and 61, which appeared to fit
the definition of a hyperplasia, because they were non-
invasive a year after nitrosourea. In the following we
show that all four non-invasive tumors analyzed here
contained indeed non-clonal aneuploid karyotypes.
A karyotype analysis of 20 cells of the non-invasive
“tumor” RMT 65 is shown in Table 2. As can be seen in
this table, 10 of 20 (50%) cells of RMT 65 contained
non-clonal aneuploid, near-tetraploid karyotypes. The
remaining 10 RMT 65 cells contained normal tetraploid
karyotypes (not shown). We remind the reader that
tetraploidy is a minor, but normal variant of the diploid
karyotype. We conclude that the non-invasive RMT 65
tumor is a 50%-aneuploid, non-clonal hyperplasia, con-
sistent with our theory. The 50% of normal tetraploid
RMT 65 cells could either represent a “regenerative
hyperplasia” [50] or could be entirely normal cells.
As shown in Table 3, 11 of 20 cells of the non-invasive
“tumor” RMT 58 contained non-clonal aneuploid karyo-
types. The remaining nine cells contained normal diploid
karyotypes (not shown). It follows that the non-invasive
“tumor” RMT 58 was a 55%-aneuploid, non-clonal
hyperplasia.
As shown in Table 4, 17 of 20 cells of the non-invasive
“tumor” RMT 54 contained non-clonal aneuploid karyo-
types. The remaining three cells were normal diploid
cells (not shown). Thus RMT 54 was an 85%-aneuploid,
non-clonal hyperplasia.Finally, we show in Table 5 that 12 of 20 cells of the
non-invasive “tumor” RMT 61 contained non-clonal an-
euploid karyotypes. Five of these cells consisted of
near-diploid aneuploid, and seven of near-tetraploid
aneuploid karyotypes. The remaining eight cells were five
Table 3 Non-clonal hyperplasia RMT 58: 11 aneuploid cells in a sample of 20
Karyotypes 1 2 3 4 5 6 7 8 9 10 11
Total no. of chromosomes 35 42 32 32 32 35 41 38 39 41 41
Chromosomes
1 1 3 2 2 2 2 2 2 2 2 2
2 2 2 1 1 1 1 3 2 2 2 2
3 2 2 2 2 2 1 2 1 2 2 2
4 2 2 2 2 2 2 2 2 2 2 2
5 2 2 1 1 1 1 2 2 1 2 2
6 2 2 2 2 1 2 2 1 2 2 2
7 1 2 2 2 2 2 2 2 2 2 2
8 1 2 0 1 2 1 1 2 2 2 2
9 2 2 1 2 0 2 2 2 1 2 2
10 1 2 2 1 2 1 2 2 2 2 2
11 1 2 2 1 2 2 2 2 2 2 2
12 2 2 1 3 1 2 2 2 2 2 2
13 2 2 2 3 2 2 2 2 1 2 2
14 2 1 1 2 2 2 2 2 2 2 2
15 2 2 0 1 1 2 1 2 2 2 2
16 2 2 1 0 2 2 2 2 2 2 2
17 2 2 2 2 1 2 2 2 2 1 1
18 1 2 2 0 2 1 2 1 2 2 2
19 2 2 2 1 2 2 2 2 2 2 2
20 1 2 2 2 1 1 2 2 2 2 2
X 2 2 2 1 1 2 2 1 2 2 2
Y 0 0 0 0 0 0 0 0 0 0 0
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shown). Thus RMT 61 was a 60%-aneuploid, non-clonal
hyperplasia.
In sum, the four non-invasive, nitrosourea-induced rat
tumors analyzed here had 50-85%-aneuploid, non-clonal
karyotypes. These results confirm and extend the results
of Goepfert et al., who found that the aneuploid frac-
tions of cells of the “preneoplastic phase” of nitrosourea-
treated rats “ranged from 35 up to 82%” [47].
In the following we list parallel rat-, other animal- and
human preneoplastic systems, in which persistent prolif-
erative hyperplasias with non-clonal aneuploidies have
been observed previously (see also Background):
(1)Studying rat tracheal primary cells 5–6 weeks after a
single treatment with nitrosoguanidine Barrett et al.
observed in 1988 that selection for “enhanced
growth” coincided with non-clonal, “abnormal kar-
yotypes” [51]. Non-clonal aneuploid “hyperplasias”
were also observed (a) in rats treated with nitrosa-
mine for 10 weeks in 2009 [52], (b) in rats treated
“early”, from 8 to 57 days with methylcholanthrenein 1975 [53,54], and (c) in rats treated “early”, from
2.5 to 6 months after treatments with azo-dyes and
radiation in 1960 and 1963 [55,56] and with butter
yellow in 1957 [57].
(2)Enhanced or hyperplastic growth segregating with
non-clonal aneuploidy was also observed (a) by
Levan in spontaneously transforming mouse cells
in vitro in 1958 [10], (b) and by Hauschka in
carcinogen-treated mice, “One of the first precan-
cerous reactions was the appearance of numerous
mitotic abnormalities with a frequency of up to 60
percent” [21] and (c) by Nowell in cells of irradiated
mice, “… with extensive chromosome changes [that]
may persist in the hematopoietic tissues for long
periods after irradiation without leukemia arising”
[22].
(3)Preneoplastic non-clonal aneuploid hyperlasias have
also been observed by Awa et al. in cancer-free atom
bomb survivors after 1945 as “Persistent chromo-
some aberrations in the somatic cells of A-bomb
survivors, Hiroshima and Nagasaki”, in 1974, 1991
and 1997 [25-27].
Table 4 Non-clonal hyperplasia RMT 54: 17 aneuploid cells in a sample of 20
Karyotypes 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Total no. of chromosomes 43 35 42 42 42 42 42 42 42 42 42 42 42 42 41 42 42
Chromosomes
1 3 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
3 1 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
4 2 1 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2
5 2 2 2 2 2 2 2 3 2 2 2 2 2 2 2 2 2
6 2 1 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
7 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
8 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
9 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
10 2 2 1 2 2 2 2 2 1 2 2 2 2 2 2 2 2
11 2 1 2 1 2 2 2 2 2 1 1 2 2 2 2 2 2
12 2 1 2 2 2 1 2 2 1 2 2 2 2 2 2 2 2
13 2 1 3 3 2 2 2 2 2 2 3 1 2 2 2 2 2
14 2 2 2 3 3 2 2 2 2 2 3 2 3 2 2 2 2
15 2 1 1 1 1 2 2 2 2 2 1 2 1 2 2 2 2
16 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
17 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
18 2 2 2 2 2 2 1 2 2 2 2 2 2 1 2 2 2
19 1 1 2 2 1 2 2 2 2 2 2 1 2 1 1 1 2
20 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
X 1 2 2 2 2 2 2 1 2 1 2 2 2 1 2 2 1
Y 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
der(3) 1 1 1 1 1 1 1 0 0 0 0 1 0 0 0 0 0
der(8) 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 1 0
der(2) 1 1 1 0 0 0 0 0 1 1 0 0 0 2 0 0 1
der(13) 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0
der(5) 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0
der(9) 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0
Bloomfield et al. Molecular Cytogenetics  (2014) 7:71 Page 10 of 19(4)Preneoplastic non-clonal aneuploidy was also
observed (a) in irradiated human T-cells prior to
neoplastic transformation [58], (b) in aneuploid
hyperplasia derived from irradiated human lympho-
cytes in 1996 [59], and (c) in 1998 as “A typical fea-
ture of chromosomal instability in primary human
G0-lymphocytes exposed to gamma-irradiation …
[causing] the appearance of novel aberrations in the
clonal progeny of the irradiated cell, many genera-
tions after the exposure” [23].
(5)Preneoplastic, non-clonal aneuploidy was also found
in precursors of spontaneously transformed Chinese
hamster cells [60], and in our lab in preneoplastic
Chinese hamster cells treated with nitrosourea [61].In sum, all of these prior studies confirm the occur-
rence of non-clonal, persistent hyperplasias prior to the
origins of immortal neoplastic clones or clonal cancers,
but a coherent theory did not emerge. For example,
Barrett et al. closed their study (listed as example (1)
above) on the non-clonal preneoplastic hyperplasias of
rat cells treated with nitrosoguanidine, “These aneuploid
cells clearly have a selective advantage in this system but
the reasons for this are unclear” [51].
Test-2-specific conclusion
We conclude that the 1-to-1 correlations between non-
clonal, preneoplastic aneuploidy and hyperplasia observed
in rats here and in rats, mice, hamsters and humans
Table 5 Non-clonal hyperplasia RMT 61: 12 aneuploid cells in a sample of 20
Karyotypes 1 2 3 4 5 6 7 8 9 10 11 12
Total no. of chromosomes 45 40 43 43 43 82 82 84 82 85 85 86
Chromosomes
1 2 2 2 2 2 4 4 4 4 4 4 4
2 3 2 2 2 2 3 4 4 4 4 4 4
3 2 2 2 2 2 4 4 4 4 4 4 4
4 2 2 2 2 2 4 4 4 4 4 4 4
5 2 2 2 2 2 4 4 4 4 4 4 4
6 2 2 2 2 2 4 4 4 4 4 4 4
7 2 2 2 2 2 4 3 4 4 4 4 4
8 2 2 2 2 2 4 4 4 4 4 4 4
9 2 2 2 2 2 4 4 4 4 4 4 4
10 2 2 2 2 2 4 4 4 4 4 4 4
11 2 2 2 2 2 3 4 4 4 4 4 4
12 2 2 2 2 2 4 3 5 4 4 4 4
13 3 2 2 2 2 4 4 4 4 4 4 4
14 2 2 2 2 2 4 4 4 4 4 4 4
15 2 1 2 2 2 4 4 4 3 5 5 4
16 3 1 2 2 2 4 4 4 4 4 4 4
17 2 2 2 2 2 4 4 4 4 4 4 4
18 2 2 2 2 2 4 4 4 4 4 4 4
19 2 2 2 2 2 4 4 4 3 4 4 4
20 2 2 2 2 2 4 4 4 4 4 4 4
X 2 2 2 2 2 4 4 3 4 4 4 6
Y 0 0 0 0 0 0 0 0 0 0 0 0
der(?) 0 0 1 0 0 0 0 0 0 0 0 0
broken X 0 0 0 1 0 0 0 0 0 0 0 0
der (7 ?) 0 0 0 0 1 0 0 0 0 0 0 0
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theory that non-clonal hyperplasias with varying aneu-
ploidies may persist over years until they are displaced by
clonal immortal cancers or perish (Figure 1).
Nevertheless, the significance of the persistent preneo-
plastic aneuploidies for carcinogenesis observed here in
rats and in the different systems listed above depends on
proof that these aneuploidies are precursors of the
karyotypes of clonal cancers. To test this prediction, we
have investigated next, whether the four aneuploid rat
hyperplasias studied here (Table 1) generate new clonal
neoplasias spontaneously.
This seemed plausible; because we found recently that
non-clonal hyperplasias induced in human skin cells by
treatments with artificially over-expressed hypothetical
cancer genes persisted over 100 generations in vitro prior
to the formation of immortal neoplastic clones. New
immortal and tumorigenic clones only evolved after over
100 aneuploid cell generations in vitro [24,62].Test-3: do non-clonal hyperlasias generate clonal cancers
spontaneously but rarely?
The speciation theory predicts that the inherently variable
aneuploidies of preneoplastic hyperplasias function as pre-
cursors for the stochastic evolution of cancer karyotypes
(See Figure 1). To test this prediction we have analyzed cul-
tures of the four non-clonal and noninvasive hyperplasias
RMT 65, 58, 54 and 61 (Tables 1, 2, 3, 4 and 5) in vitro,
allowing time for the spontaneous evolution of new neo-
plastic clones.
Surprisingly all four non-clonal and non-invasive rat
hyperlasias evolved new three-dimensionally growing foci
of clonal neoplasias (CN) within a few months of propaga-
tion in vitro. Hence, we called these clones RMT-CN 65,
58, 54 and 61. The relatively fast evolutions of new neo-
plastic clones within a few months in culture may be due
to the high mitotic rates of the hyperplastic rat cells in cul-
ture. By contrast, growth in vivo must be more restrained
or else the hyperplasias would outgrow the rats within
Bloomfield et al. Molecular Cytogenetics  (2014) 7:71 Page 12 of 19much less than a year. Recently we have also observed
similar high growth rates in aneuploid hyperplastic human
cells in cell culture [24].
To determine, whether the karyotypes of these new neo-
plastic clones were clonal, arrays of 20 karyotypes were pre-
pared as described above (Test-1: are carcinomas late and
carry individual clonal karyotypes and phenotypes?). Repre-
sentative karyotypes of the four new neoplastic clones
RMT-CN 65, 58, 54 and 61, are shown in Figure 2C,D,E
and F respectively. As can be seen in Figures 6, 7, 8 and 9,
each of the four new neoplastic rat clones, RMT-CN 65, 58,
54 and 61 had an individual, quasi-clonal karyotype, as is
typical of cancer cells. The karyotype of RMT-CN 61 con-
sisted of a near-diploid and a near-tetraploid clone. Since a
pair of identical marker chromosomes in primary cancers
is extremely rare, the presence of three such markers in the
tetraploid variant proves that it derived from the diploid
variant by a form of endomitosis.
As expected from the karyotypic clonality of the RMT-CN
65, 58, 54 and 61 clones, we found that each of the four neo-
plastic clones encodes an individual, clonal cellular pheno-




















Figure 6 Karyotype array of the clonal neoplasia RMT-CN 65, which e
array of the clonal neoplasia RMT-CN 65 was prepared from a three-dimen
non-clonal aneuploid mammary hyperplasia RMT 65 within several months
that the numbers of RMT-CN 65 chromosomes per cell were quasi-clonal, a
numbers were 83-100%-clonal, and that the RMT-CN 65 karyotype is individTest-3-specific conclusions
1) The spontaneous evolutions of new individual
neoplastic clones from 4-of-4 non-clonal rat
hyperplasias with varying aneuploidies within
several months in culture is proof-of-principle,
that aneuploid hyperplasias are sufficient to
generate carcinomas with new clonal
karyotypes.
2) Our finding that the four new clonal neoplasms
and the two rat carcinomas described above each
have individual clonal karyotypes indicates that
they each evolved independently by unique
karyotypic rearrangements of single cells out of
millions of non-clonal, hyperplastic cells with
varying aneuploidies. The low probability of such
events would explain the individuality of cancer
karyotypes.
In following we have asked, What is the mechanism
that generates the rare and unique cancer karyotypes
from aneuploid hyperplasias?Clonal Neoplasia RMT–CN 65
Avg chromo no SD
n=23
50 3
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der(4) 1 (4)








volved from a non-clonal rat mammary hyperplasia. The karyotype
sionally growing focal colony that had evolved from a culture of the
in culture (Table 2). The karyotype array and the attached table show
veraging 50 ± 3. The data also show that the chromosome copy
ually distinct from those shown in Figures 3 and 5.
Clonal Neoplasia RMT-CN 58 
Avg chromo no SD
n=20
74 3
Cells with Non-Clonal Marker(s)
Chromosomes Copy no (% clonal) 1 
1 5 (55) der(12;11) 1 (10)
2 3 (75) der(1;10) 1 (5)
3 3 (80) der(6) 1 (5)
4 4 (75) der(X) 1 (5)
5 3 (90) der(8) 1 (5)
6 3 (90) 1 of 3 @ 3
7 4 (70) der(1) 1 (5)
8 2 (100) der(1;7) 1 (5)
9 4 (85) der(7) 1 (5)
10 3 (75) 2 of 3 @ 3
11 3 (70) der(2;7) 1 (5)
12 5 (95) der(15;2) 1 (5)
13 4 (65) der(16;11;5) 1 (5)
14 2 (70) 3 of 3 @ 3
15 3 (75) i(8q) 1 (5)
16 4 (95) der(12;14) 1 (5)
17 3 (95) der(10;14) 1 (5)
2@1)09(381
19 4 (85) der(3;4) 1 (5)
20 3 (70) der(1;17) 1 (5)
1@ 5)57(4X
Y 0 der(12;11) 1 (10)
der(10;8) 1 (95) der(7;10) 1 (5)
der(14;8) 2 (90) i(4q) 1 (5)
der(16;11) 1 (75) der(14;7) 1 (5)
der(8;14) 1 (70) der(5;11) 1 (5)


































































































































Figure 7 Karyotype array of the clonal neoplasia RMT-CN 58, which evolved from a non-clonal rat mammary hyperplasia. The karyotype array of
the neoplastic clone RMT-CN 58 was prepared from a three-dimensionally growing focal colony that had evolved from a culture of the non-clonal
aneuploid mammary hyperplasia RMT 58 within several months in culture (Table 3). The karyotype array and the attached table show that the numbers of
RMT-CN 58 chromosomes per cell were quasi-clonal, averaging 74 ± 3. The data also show that the copy numbers of the normal and of four clone-specific
marker chromosomes of RMT-CN 58 were 55-100%-clonal. The individuality of the RMT-CN 58 karyotype is again evident from comparisons with the
karyotype arrays of the carcinomas RMT 47–3 and 37–2 and the neoplastic clone RMT-CN 65 shown in Figures 3, 5 and 6. The RMT-CN 58 clone stands
out by a high level of ongoing karyotypic variations, generating karyotypes with up to five new non-clonal aneusomies per cell.
Bloomfield et al. Molecular Cytogenetics  (2014) 7:71 Page 13 of 19Do cancer karyotypes evolve with all clonal aneusomies
in single-steps?
To define the question about the origin of cancer karyo-
types, we have added up all clonal aneusomies of each of
the two carcinomas and the four new clonal neoplasias
analyzed here, based on the data summarized in Figures 3,5, 6, 7, 8, 9 and the accompanying tables: There were 3
clonal aneusomies in RMT 47–3, 5 in RMT 37-2-Clone 1,
8 in RMT-CN 65, 23 in RMT-CN 58, 5 in RMT-CN 54
(relative to normal tetraploidy) and 4 in RMT-CN 61. So
the question is, were all 3 to 23 aneusomies of these
cancers accumulated gradually or in single-steps? The
Figure 8 Karyotype array of the clonal neoplasia RMT-CN 54, which evolved from a non-clonal rat mammary hyperplasia. This karyotype array
of the neoplastic clone RMT-CN 54 was prepared from a three-dimensionally growing colony that had evolved from a culture of the non-clonal aneuploid
mammary hyperplasia RMT 54 within several months in culture (Table 4). The karyotype array and the attached table show that the RMT-CN 54 clone
contained per cell a quasi-clonal, near-tetraploid average number of 80 ± 2 chromosomes. The data also show that the chromosome copy numbers of the
clone were 80-100%-clonal, based on a normal tetraploid karyotype. The individuality of the RMT-CN 54 karyotype array is again evident from comparisons
with the karyotype arrays of the carcinomas RMT 47–3 and 37–2 and of the clonal neoplasias RMT-CN 65 and 58 shown in Figures 3, 5, 6 and 7.
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the following testable predictions:
The gradual mechanism predicts that karyotypic precur-
sors of cancer cells with sub-cancerous combinations of
aneusomies must be stable, because they must survive long
enough to allow the accumulation of further cancer-specific
aneusomies over subsequent cell generations to become
cancer cells. In order to persist during further cell genera-
tions, such intermediates would have to be stabilized against
destabilizing aneuploidy by selections for some cancer-
specific phenotypes, e.g. immortality. The resulting clones of
incomplete complements of cancer-specific aneusomies
would then accumulate in preneoplastic tissues and would
then enhance the probability of carcinogenesis [63]. But
there is no evidence for such non-neoplastic clones in the
karyotypes of the hyperplasias shown in Tables 2, 3, 4 and 5.
The single-step mechanism predicts that all clonal aneu-
somies of a cancer karyotype have to be acquired at once,
because all non-cancerous combinations of aneusomies
are unstable (Figure 1). In agreement with this prediction
the karyotypes of all carcinomas and neoplastic clones
were clonal, whereas the karyotypes of all non-cancerous
hyperplasias were non-clonal (Figures 3, 5, 6, 7, 8, 9 and
Tables 2, 3, 4 and 5). Accordingly, the non-clonalaneusomies of aneuploid hyperplasias and those spontan-
eously generated by clonal cancers were never seen twice
in a given set of 20 karyotypes (Figures 3, 5, 6, 7, 8, 9) or
in consecutive karyotypes of the same culture (not shown
here). Prior studies from Heng et al. [64] and from our lab
confirm these observations [17,19,24,61,65].
It would follow that the aneuploid cells of non-clonal
hyperplasias are too short-lived for the gradual accumula-
tion of cancer-specific aneusomies over many cell genera-
tions. In view of this we conclude that cancer karyotypes
evolve with all clonal aneusomies in single-steps. This
view is supported by independent genetic evidence for
“simultaneous gains of chromosomes in a single mitosis”
in carcinogenesis, as for example by simultaneous tetra-
ploidization of allelic chromosome pairs [66].Deductions from the single-step mechanism of carcinogenesis
The low odds of forming the new clonogenic karyotype
of an autonomous cancer species by the assembly of
multiple, inherently unstable aneusomies in a single-step
explain the low probability of carcinogenesis and conse-
quently also the long latencies and individualities of
cancers.
Clonal Neoplasia RMT-CN 61




Chromosomes Copy no (% clonal)
1 2 (89) 4 (73)
2 2 (89) 4 (55)
3 2 (100) 4 (73)
4 2 (100) 4 (91)
5 2 (89) 4 (100)
6 2 (89) 4 (100)
7 2 (89) 4 (91)
8 2 (89) 4 (73)
9 2 (89) 4 (82)
10 2 (89) 4 (100)
11 2 (89) 4 (82)
12 2 (78) 4 (73)
13 2 (89) 4 (73)
14 2 (100) 4 (64)
15 2 (89) 4 (73)
16 2 (89) 4 (82)
17 1 (78) 2 (91)
18 1 (89) 2 (100)
19 2 (89) 4 (91)
20 2 (100) 4 (82)
X 2 (78) 4 (82)
Y 0 0
der (17;4) 1 (78) 2 (82)
der (18;17) 1 (78) 2 (82)
der (18;4) 1 (11) 2 (18)
Cells with Non-Clonal Markers
1 @ 1













































Clonal Neoplasia RMT-CN 61 
Figure 9 Karyotype arrays of two related clonal neoplasias RMT-CN 61, which evolved from a non-clonal rat mammary hyperplasia.
The two related karyotype arrays shown here on the same plot were prepared from three-dimensionally growing neoplastic foci termed RMT-CN
61, which had evolved from a culture of the non-clonal aneuploid mammary hyperplasia RMT 61 within several months (Table 5). A glance at the
two karyotype-arrays of the RMT-CN 61 foci shows two closely related clonal karyotypes, one near-diploid and the other near-tetraploid. The two
RMT-CN 61 clones contained quasi-clonal chromosome numbers, which averaged 46 ± 8 and 82 ± 5 per cell, respectively. The copy numbers of
their normal chromosomes and their common and individual marker chromosomes were 73-100%-clonal. The individuality of the two sister
clones is evident from comparisons of their karyotype arrays with the five individual karyotype arrays of the two rat carcinomas and the three
neoplastic rat clones shown in Figures 3, 5, 6, 7 and 8.
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solves an old paradox of the mutation theory, first
pointed out by Rous in 1959 and later by Wolman, that
there are very few, if any potential intermediates in car-
cinogenesis [67,68]. Take the absence of non-cancerous
metastases or of immortal but non-cancerous somatic
cells as examples.
Discussion
Here we asked whether the long latent periods from car-
cinogen to cancers and the individuality of the karyo-
types and phenotypes of cancers could be explained by
the theory that carcinogenesis is a form of speciation.
A coherent karyotypic explanation for the long latencies
of carcinogenesis and the individuality of cancers
Based on our experiments and the literature on carcino-
genesis in rats injected with nitrosourea we found the fol-
lowing chain of events in support of the speciation theory:
(1) Nitrosourea induces aneuploidy in rat mammary tissue
within 1-day after injection [47]. (2) By unbalancing thekaryotype, aneuploidy sets off automatic karyotypic varia-
tions. Selections for variants with proliferative phenotypes
then generate persistent hyperplasias with varying aneu-
ploidies beginning two months after injection of nitro-
sourea [44,47,48,52]. (3) Eventually, from about six
months after nitrosourea and later rare autonomous can-
cers with individual clonal karyotypes evolve, which dis-
place the non-clonal and non-autonomous hyperplasias
[44,47,48,52]. Since generating a new autonomous cancer
cell by random karyotypic variations is inevitably highly
inefficient, this mechanism predicts (a) the long latent pe-
riods from carcinogens to cancers and (b) the individuality
and clonality of cancer karyotypes. We conclude that the
speciation theory provides a coherent explanation for the
long latencies of carcinogenesis and the individuality of
cancers.
The karyotypic cancer theory advanced here derives
direct and substantial support from earlier studies by
Dulbecco and Armstrong, Aldaz et al. and Goepfert et al.
[44,47,48]. These studies described the first evidence for
persistent and aneuploid preneoplastic hyperplasias and
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nitrosourea system. However, a coherent theory about the
roles of karyotypes in carcinogenesis did not emerge, be-
cause common cancer-specific gene-mutations [46,48,69-71]
or cancer-specific aneusomies were expected but not found
[44,47]. The individual karyotypes and inconsistent muta-
tions (see also next) that were found can, however, now be
explained by the speciation theory.
Single-step origins of cancer-specific karyotypes
The karyotypes of the individual cancers studied here and
previously differ from those of corresponding normal cells
in multiple numerical and structural chromosome alter-
ations or aneusomies [19,20]. These individual chromo-
some alterations could have been picked up gradually or
in single-steps.
The gradual mechanism of accumulating chromo-
somal alterations predicts stable precursors in the form
of sub-clonal karyotypic intermediates, which we did not
observe. Instead, we have found only unstable aneuploid
karyotypes in preneoplastic or hyperplastic cells here
(Tables 2, 3, 4 and 5) and previously [24,61]. In view of
this and the clonal and stable karyotypes of cancers, we
concluded that cancer karyotypes must be generated in
single-steps, because all non-cancerous aneuploidies are
unstable.
Our conclusion is supported by an earlier genetic study
of Paulsson et al., who found that the karyotypes of spe-
cific leukemias were generated “by simultaneous gain of
chromosomes in a single mitosis” [66]. It would follow
that carcinogenesis is indeed a sudden or saltational speci-
ation event [33,35-37,65,72], as has been postulated for
conventional speciation [72-77].
There is, however, a competing theory, which argues that
gene mutations are necessary for carcinogenesis, which we
discuss briefly.
Is a gene mutation necessary for nitrosourea-induced
carcinogenesis in rats?
Based on a first set of consistent correlations, it has been
argued in 1983 that mutations of the cellular H-ras gene
are necessary for carcinogenesis in rats injected with
nitrosourea [46]. But subsequent studies in this system
have shown either inconsistent correlations of carcin-
omas with H-ras mutations [47,69,70] or no correlations
at all [71]. Moreover, transgenic ras genes that were even
artificially overexpressed by heterologous promoters
proved to be heritable, rather than lethal in mice [78,79].
If tumors developed, those only appeared late in adult
mice and, if tested, contained individual clonal karyo-
types [18]. Thus proof for a specific oncogenic function
of mutant ras genes is necessary to confirm a direct role
in cancer. But this has not been accomplished yet
[80-82].Our new results, that each rat carcinoma and each neo-
plastic rat clone has its own individual karyotype and
phenotype, now raise new unanswered questions about
the role of common mutations, as for example of H-ras,
in cancers. How would common mutations explain the in-
dividualities of cancers?
In view of this we deduce from our current study that
the individual phenotypes of the rat carcinomas are
encoded by individual karyotypes, independent of muta-
tions, as we have recently shown for the individualities of
human cervical carcinomas [49].
Conclusions
Based on earlier studies of carcinogenesis in the nitro-
sourea-rat mammary tumor system Dulbecco and Arm-
strong proposed in 1988, “The similarities between the rat
and the human neoplasias suggest that the present find-
ings may be relevant for the evaluation of preneoplastic le-
sions in breast cancer. If the potential for invasion is also
built in human breast cancers from their inception, any
evidence pointing to the evolution of a lesion towards ma-
lignancy … would have to be considered as an indication
of the progressive potential of the lesion” [48]. Our results
suggest that the relevant and testable “preneoplastic le-
sions … to be considered” are the karyotypes of human
mammary hyperplasias and cancers.
Our conclusion derives direct support from earlier
studies of human breast cancers, finding cancer-specific
“nuclear DNA content as an objective biological marker
of tumor aggressiveness” [83], and finding that cancer-
specific gene expressions are directly proportional to
cancer-specific “DNA copy numbers” [84].
Methods
Mammary carcinomagenesis in rats injected with a single
dose of nitrosourea
The induction of mammary tumors in inbred female rats
by single injections of 5 mg of nitrosourea followed
long-established procedures [45-48], specifically those
described by Aldaz et al. in 1992 [44].
Cells and cell culture
Rat mammary tumors (RMT) were explanted from rats
about 1 year after injection with 5 mg of nitrosourea as
described by Aldaz et al. [44]. Explanted tissues were
minced with scalpels and dissociated into single cell popu-
lations with trypsin. Cells were then propagated in cell
culture medium RPMI 1640 (Sigma Co) supplemented
with 5% or 10% fetal calf serum, 1% Anti-Anti (GibCo
Company) and 1% Nystatin (Sigma Company).
Karyotype analysis
One to two days before karyotyping, cells were seeded
at about 50% confluence in a 5-cm culture dish with
Bloomfield et al. Molecular Cytogenetics  (2014) 7:71 Page 17 of 193 ml medium containing 5% fetal calf serum. After
reaching ~75% confluence, 250 ng colcemid in 25 μl solu-
tion (KaryoMax, Gibco) was added to 3 ml medium. The
culture was then incubated at 37°C for 4–8 hrs. Subse-
quently cells were dissociated with trypsin, washed once
in 3 ml of physiological saline and then incubated in
0.075 molar KCl at 37°C for 15 min. The cell suspen-
sion was then cooled in ice-water, mixed (‘prefixed’)
with 0.1 volume of the freshly mixed glacial acetic acid-
methanol (1:3, vol. per vol.) and centrifuged at 800 g
for 6 minutes at room temperature. The cell pellet was
suspended in about 100 μl supernatant and than
mixed drop-wise with 5 ml of the ice-cold acetic acid
methanol solution and incubated at room temperature
for 15 min. This cell suspension was then pelleted
once more as above and re-suspended in a small
volume of the acetic acid-methanol solution. An appropri-
ate aliquot was transferred with a micropipette tip to a
glass microscope slide and allowed to evaporate at room
temperature. Slides with suitable metaphase chromosome
spreads were hybridized with chromosome-specific-color-
coded DNA probes as described by the manufacturer
(MetaSystems, Newton, MA 02458). Karyotypes were then
prepared as described by us previously [17,49].
Note: All work on animals has been approved by the
Animal Care and Use Committee of the University of
California at Berkeley.
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